Crescent Biopharma, Inc. (CBIO) Operating cash flow 2016–2025
Crescent Biopharma, Inc. (CBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$71.5MFY2025 · since FY2016: -$29.7M → -$71.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$71.5M | -130.0% |
| FY2024 | -$31.1M | +10.8% |
| FY2023 | -$34.9M | +24.9% |
| FY2022 | -$46.5M | +19.2% |
| FY2021 | -$57.5M | -46.5% |
| FY2020 | -$39.2M | +24.5% |
| FY2019 | -$52.0M | -20.0% |
| FY2018 | -$43.3M | -45.6% |
| FY2017 | -$29.8M | -0.1% |
| FY2016 | -$29.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice